In Premenstrual syndrome (PMS) Premenstrual syndrome is a combination of physical and emotional disturbances that occurs when a woman’s menstruation comes to an end. Pampra Spas 325 mg/25 mg Tablet helps ease the symptoms of PMS such as bloating, swelling, feelings of fullness, and other signs of water weight gain. Pampra Spas 325 mg/25 mg Tablet also relieves pain, cramp and headaches associated with PMS. Altogether, this medicine will help ease discomforts and improve your mood. Lifestyle changes such as regular exercise, yoga, a healthy diet and getting plenty of sleep may also be helpful.
It is unsafe to consume alcohol with Pampra Spas 325 mg/25 mg Tablet.
Information regarding the use of Pampra Spas 325 mg/25 mg Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Pampra Spas 325 mg/25 mg Tablet during breastfeeding is not available. Please consult your doctor.
Pampra Spas 325 mg/25 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Pampra Spas 325 mg/25 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Pampra Spas 325 mg/25 mg Tablet may be needed. Please consult your doctor. However, Pampra Spas 325 mg/25 mg Tablet contains paracetamol which is considered the safest painkiller for kidney disease patients.
Pampra Spas 325 mg/25 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Pampra Spas 325 mg/25 mg Tablet may be needed. Please consult your doctor. However, the use of Pampra Spas 325 mg/25 mg Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Pampra Spas 325 mg/25 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Mylan Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Anthus Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)